Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : Glaxf crawled date : 2021 - 11 - 05 save search
GSK announces positive Phase III efficacy and safety data for daprodustat in patients with anaemia due to chronic kidney disease
Published: 2021-11-05 (Crawled : 22:00) - biospace.com/
GLAXF | $20.2 0.65% -14.18% 40
|
Health Technology
|
| O: 3.11%
H: 0.0%
C: 0.0%
GSK | $39.27 -0.83% 0.26% 1.9M
|
Health Technology
|
| O: 0.05%
H: 0.0%
C: 0.0%
disease positive kidney
NeuroBo Pharmaceuticals Appoints Gil Price, M.D. as President and Chief Executive Officer
Published: 2021-11-04 (Crawled : 02:00) - biospace.com/
GLAXF | $20.2 0.65% -14.18% 40
|
Health Technology
|
| O: 2.29%
H: 0.0%
C: -2.0%
AZNCF | $138.24 -1.36% -4.19% 800
|
Health Technology
|
| O: 0.13%
H: 0.58%
C: 0.58%
GSK | $39.27 -0.83% 0.26% 1.9M
|
Health Technology
|
| O: -1.29%
H: 0.0%
C: 0.0%
SRPT | $116.55 -1.14% -1.12% 500K
|
Health Technology
|
| O: 1.7%
H: 0.0%
C: 0.0%
NRBO | $3.44 -0.58% -1.02% 23K
|
Health Technology
|
| O: 0.25%
H: 0.0%
C: 0.0%
AZN | $68.36 -0.25% -0.25% 3.6M
|
Health Technology
|
| O: -0.05%
H: 0.0%
C: 0.0%
Gainers vs Losers
| 60% | 40% |
Top 10 Gainers
AGBA | News | $1.03 157.5% 57.94% 120M
|
Finance
ZCMD | $1.45 5.84% 52.1% 2.3M
|
Commercial Services
INVO | $1.52 100.0% 51.13% 5M
|
Health Technology
ISPC | $0.421 97.65% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.5 45.65% 470K
|
OST | $0.509 23.81% 45.26% 90K
|
GDHG | $0.263 21.76% 40.66% 3.1M
|
XPON | News | $3.15 63.21% 37.74% 16M
|
TIRX | $0.8 65.02% 30.74% 58M
|
BNTC | News | $6.82 42.08% 30.64% 3.5M
|
Health Technology
Your saved searches
Save your searches and get alerts when important news are released.